Pavan Green Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 3.10 Cr
as on 12-07-2024
- Company Age 33 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.29 Cr
as on 12-07-2024
- Revenue 46.25%
(FY 2019)
- Profit -130.58%
(FY 2019)
- Ebitda -365.72%
(FY 2019)
- Net Worth -26.03%
(FY 2019)
- Total Assets -22.06%
(FY 2019)
About Pavan Green Bio-Technologies
The Corporate was formerly known as Pavan Turnkey Projects Company Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.10 Cr.
The company currently has active open charges totaling ₹1.29 Cr.
Uttam Belkune, Ankush Belkune, and Ashwini Deshmukh serve as directors at the Company.
- CIN/LLPIN
U70102MH1990PLC059306
- Company No.
059306
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Dec 1990
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pavan Green Bio-Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttam Belkune  | Director | 27-Nov-2018 | Current |
| Ankush Belkune | Director | 10-Jun-2013 | Current |
| Ashwini Deshmukh | Director | 13-May-2016 | Current |
Financial Performance and Corporate Structure Insights of Pavan Green Bio-Technologies.
Pavan Green Bio-Technologies Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 46.25% increase. The company also saw a substantial fall in profitability, with a 130.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pavan Green Bio-Technologies?
In 2019, Pavan Green Bio-Technologies had a promoter holding of 36.00% and a public holding of 64.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 03 Feb 2014 | ₹0.80 M | Open |
Canara Bank Creation Date: 18 Mar 2009 | ₹0.95 M | Open |
Bank Of India Creation Date: 13 Mar 2007 | ₹1.12 Cr | Open |
How Many Employees Work at Pavan Green Bio-Technologies?
Unlock and access historical data on people associated with Pavan Green Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pavan Green Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pavan Green Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
